MDNAF (Medicenna Therapeutics) Days Payable: 0.00 (As of Mar. 2026)

What is Medicenna Therapeutics Days Payable?

Medicenna Therapeutics MDNAF +9.49% 29 Days Payable is 0.00 as of Mar. 2026. GuruFocus rates MDNAF with a GF Score™ of 29/100. The stock has 1 warning sign investors should review. Among 703 Biotechnology companies, Medicenna Therapeutics ranks worse than 142247.37% on this metric.

Medicenna Therapeutics's average Accounts Payable for the three months ended in Mar. 2026 was $3.31 Mil. Medicenna Therapeutics's Cost of Goods Sold for the three months ended in Mar. 2026 was $0.00 Mil.

The historical rank and industry rank for Medicenna Therapeutics's Days Payable or its related term are showing as below:

MDNAF's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 113.76
* Ranked among companies with meaningful Days Payable only.

Medicenna Therapeutics's Days Payable stayed the same from Mar. 2025 (0.00) to Mar. 2026 (0.00). stayed the same

Medicenna Therapeutics Days Payable Related Terms

Medicenna Therapeutics Days Payable Historical Data

* Premium members only.

The historical data trend for Medicenna Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicenna Therapeutics Days Payable Chart

Medicenna Therapeutics Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

Mar26

Days Payable

Get a 7-Day Free Trial

0.00

Medicenna Therapeutics Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Days Payable	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

MDNAF vs VRTX, REGN, ALNY: Days Payable Comparison

For the Biotechnology subindustry, Medicenna Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medicenna Therapeutics Days Payable vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medicenna Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Medicenna Therapeutics's Days Payable falls into.

Save Embed

29GF Score

Medicenna Therapeutics Corp MDNAF

Days Payable is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Medicenna Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Medicenna Therapeutics's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as

	Days Payable (A: Mar. 2026 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Mar. 2025 )	+	Accounts Payable (A: Mar. 2026 ))	/	count )	/	Cost of Goods Sold (A: Mar. 2026 )	*	Days in Period
=	( (1.881	+	3.534)	/	2 )	/	0	*	365
=	2.7075					/	0	*	365
=	N/A

Medicenna Therapeutics's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

	Days Payable (Q: Mar. 2026 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2025 )	+	Accounts Payable (Q: Mar. 2026 ))	/	count )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
=	( (3.082	+	3.534)	/	2 )	/	0	*	365 / 4
=	3.308					/	0	*	365 / 4
=	N/A

Frequently Asked Questions Learn more about Days Payable →

What does a Days Payable of 0.00 mean?

Medicenna Therapeutics (MDNAF) has a Days Payable of 0.00 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medicenna Therapeutics and its competitors. According to the industry distribution chart, Medicenna Therapeutics ranks #999999 out of 703 companies in the Biotechnology industry.

Is Medicenna Therapeutics' Days Payable too high?

Medicenna Therapeutics' current Days Payable is 0.00. Based on the distribution chart, Medicenna Therapeutics ranks #999999 out of 703 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Medicenna Therapeutics has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.

How does Medicenna Therapeutics' Days Payable compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, Medicenna Therapeutics ranks #999999 out of 703 companies for Days Payable. This places Medicenna Therapeutics in the lower half of its industry. The industry median Days Payable is 113.76. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Days Payable for a Biotechnology company?

The median Days Payable among Biotechnology companies is 113.76, based on 703 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Days Payable mean?

A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medicenna Therapeutics and its competitors. For the Biotechnology industry, the median Days Payable is 113.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicenna Therapeutics's current Days Payable is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Medicenna Therapeutics stock overvalued right now?

Medicenna Therapeutics (MDNAF) has a current Days Payable of 0.00. The current Days Payable is 0.00. Medicenna Therapeutics' overall GF Score™ is 29/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Days Payable calculated?

Days Payable is calculated from a company's financial statements. For Medicenna Therapeutics (MDNAF), the current Days Payable is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medicenna Therapeutics Business Description

Industry Healthcare Biotechnology

Comparable Companies XCNQ:QNTM TSXV:ALZI TSXV:SHRX TSX:BCT XCNQ:DTC TSX:RVX TSXV:TTI TSX:MBX TSXV:GSD XCNQ:LOBE VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges MDNA:Canada

Address 2 Bloor Street West, Suite 903, Toronto, ON, CAN, M4W 3E2

Website https://www.medicenna.com

Medicenna Therapeutics Corp is a Canada-based immuno-oncology company. Its principal business activity is the development and commercialization of IL-2, IL-4, and IL-13 Superkines and Empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases. Its pipeline candidates include MDNA11 for Cancer immunotherapies, MDNA55 is a Molecular Trojan Horse, and BiSKITs represent a novel platform comprised of Bifunctional SuperKine ImmunoTherapies.

29GF Score

Get the complete analysis for MDNAF

Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.30

Price

View MDNAF Analysis

See Days Payable data for all stocks →